Amidst the tariff chaos we may get clues from one of the most defensive sectors of the market-healthcare stocks. Recently we provided a playbook of positions for those actively managing their LIFE SCIENCE portfolios. However in the midst of tariff chaos and policies targeting various countries lurching weekly it will be difficult for CEOs to provide forward guidance.
On a positive note Abbott Labs beat and raised guidance and the stock is up over 5%.
======